Daptomycin Etest MICs for methicillin-resistant Staphylococcus aureus vary among different media

Journal of Infection and Chemotherapy

Volumn 18, Issue 6, 2012, Pages 970-972

  Nakashima, Hanae ^a   Takahashi, Hiroshi ^b   Kameko, Mitsuaki ^a   Saito, Hiroshi ^b  

^a Nagano Municipal Hospital   (Japan)

^b Nagano Prefectural Suzaka Hospital   (Japan)

Author keywords

Broth microdilution; Daptomycin; Etest; Methicillin resistant Staphylococcus aureus (MRSA); MIC

Indexed keywords

CALCIUM ION; DAPTOMYCIN; ANTIINFECTIVE AGENT; CALCIUM;

ACCURACY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BROTH DILUTION; CONTROLLED STUDY; ENTEROCOCCUS FAECALIS; EPSILOMETER TEST; IN VITRO STUDY; INTERMETHOD COMPARISON; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; CULTURE MEDIUM; DRUG EFFECT; HUMAN; METHODOLOGY; MICROBIAL SENSITIVITY TEST; MICROBIOLOGICAL EXAMINATION; STANDARD;

ANTI-BACTERIAL AGENTS; BACTERIOLOGICAL TECHNIQUES; CALCIUM; CULTURE MEDIA; DAPTOMYCIN; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS;

EID: 84880402588     PISSN: 1341321X     EISSN: 14377780     Source Type: Journal    
DOI: 10.1007/s10156-012-0424-5     Document Type: Article

References (10)

1. Koeth LM, Thorne GM. Daptomycin in vitro susceptibility methodology: a review of methods, including determination of calcium in testing media. Clin Microbiol News. 2010;32:161-9.
2. Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard. 8th ed. Document M07-A8. Wayne, PA: CLSI; 2009.
3. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Twentieth informational supplement. Document M100-S20. Wayne, PA: CLSI; 2010.
4. Koeth LM, DiFranco JM. Comparison of daptomycin Etest MICs on Mueller Hinton, IsoSensitest and brain heart infusion agars from Europe against 20 Staphylococcus aureus isolates. Eur J Clin Microbiol Infect Dis. 2010;29:1261-4.
5. 2+ and albumin on these drugs. Antimicrob Agents Chemother. 1991;35:1710-6.
6. Sader HS, Moet GJ, Farrell DJ, Jones RN. Antimicrobial susceptibility of daptomycin and comparator agents tested against methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: trend analysis of a 6-year period in US medical centers (2005-2010). Diag Microbiol Infect Dis. 2011;70:412-6.
7. Sader HS, Farrell DJ, Jones RN. Antimicrobial activity of daptomycin tested against gram-positive strains collected in European hospitals: results from 7 years of resistance surveillance (2003-2009). J Chemother. 2011;23:200-6.
8. Kelley PG, Gao W, Ward PB, Howden BP. Daptomycin non-susceptibility in vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous-VISA (hVISA): implications for therapy after vancomycin treatment failure. J Antimicrob Chemother. 2011;66:1057-60.
9. Panagea T, Galani I, Souli M, Karantani I, Giamarellou H, Petrikkos G. Glycopeptide and daptomycin susceptibility and vancomycin heteroresistance of methicillin-resistant Staphylococcus aureus (MRSA) clinical isolates from a Greek university hospital. Int J Antimicrob Agents. 2011;38:451-2.
10. Jevitt LA, Thorne GM, Traczewski MM, Jones RN, McGowan JE Jr, Tenover FC, et al. Multicenter evaluation of the Etest and disk diffusion methods for differentiating daptomycin-susceptible from non-daptomycin-susceptible Staphylococcus aureus isolates. J Clin Microbiol. 2006;44:3098-104. (Pubitemid 44413737)